terazosin
Selected indexed studies
- Terazosin. (, 2006) [PMID:30000707]
- Terazosin for benign prostatic hyperplasia. (Cochrane Database Syst Rev, 2002) [PMID:12519611]
- [Terazosin]. (Dtsch Med Wochenschr, 1998) [PMID:9581161]
_Worker-drafted node — pending editorial review._
Connections
terazosin is a side effect of
Sources
- Terazosin. (2006) pubmed
- Terazosin for benign prostatic hyperplasia. (2002) pubmed
- [Terazosin]. (1998) pubmed
- Terazosin attenuates abdominal aortic aneurysm formation by downregulating Peg3 expression to inhibit vascular smooth muscle cell apoptosis and senescence. (2024) pubmed
- Terazosin in the treatment of benign prostatic hyperplasia: the United States experience. (1992) pubmed
- Terazosin Stimulates Pgk1 to Remedy Gastrointestinal Disorders. (2021) pubmed
- Association of Terazosin, Doxazosin, or Alfuzosin Use and Risk of Dementia With Lewy Bodies in Men. (2024) pubmed
- Terazosin: a new alpha adrenoceptor blocking drug. (1992) pubmed
- Targeting phosphoglycerate kinase 1 with terazosin improves motor neuron phenotypes in multiple models of amyotrophic lateral sclerosis. (2022) pubmed
- Terazosin: pharmacokinetics and the effect of age and dose on the incidence of adverse events. (1991) pubmed